Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.410
-0.080 (-3.21%)
At close: Nov 20, 2024, 4:00 PM
2.580
+0.170 (7.05%)
Pre-market: Nov 21, 2024, 7:33 AM EST

Lipella Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
1.353.295.121.410.610.03
Short-Term Investments
---0.3--
Cash & Short-Term Investments
1.353.295.121.710.610.03
Cash Growth
-43.82%-35.69%198.75%182.56%2233.15%-
Other Receivables
0.030.030.11-0.070.08
Receivables
0.030.030.11-0.070.08
Prepaid Expenses
0.70.10.560.090.020.01
Total Current Assets
2.083.435.81.810.70.12
Property, Plant & Equipment
0.080.150.150.20.26-
Total Assets
2.163.585.952.010.960.12
Accounts Payable
0.460.140.380.050.020.05
Accrued Expenses
0.170.160.460.230.110.07
Short-Term Debt
--0.280.030.030.05
Current Portion of Leases
0.070.090.060.040.05-
Other Current Liabilities
----0-
Total Current Liabilities
0.70.391.180.340.210.17
Long-Term Debt
---0.050.050.05
Long-Term Leases
-0.050.10.170.21-
Other Long-Term Liabilities
0--0.030.030.02
Total Liabilities
0.70.431.270.590.490.24
Common Stock
000000
Additional Paid-In Capital
15.3613.4710.384.531.71.06
Retained Earnings
-13.9-10.32-5.7-3.11-1.24-1.18
Total Common Equity
1.463.144.681.420.46-0.12
Shareholders' Equity
1.463.144.681.420.46-0.12
Total Liabilities & Equity
2.163.585.952.010.960.12
Total Debt
0.070.140.430.280.330.1
Net Cash (Debt)
1.283.164.691.430.27-0.07
Net Cash Growth
-43.03%-32.72%227.80%420.77%--
Net Cash Per Share
1.344.219.243.361.03-0.28
Filing Date Shares Outstanding
1.090.780.720.480.480.26
Total Common Shares Outstanding
1.090.760.720.480.290.26
Working Capital
1.383.044.621.470.49-0.05
Book Value Per Share
1.344.166.512.941.61-0.46
Tangible Book Value
1.463.144.681.420.46-0.12
Tangible Book Value Per Share
1.344.166.512.941.61-0.46
Machinery
0.140.140.13---
Source: S&P Capital IQ. Standard template. Financial Sources.